305 related articles for article (PubMed ID: 22446380)
21. Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells.
Mishra N; Reddy KS; Timilsina U; Gaur D; Gaur R
J Cell Biochem; 2018 Aug; 119(8):6695-6703. PubMed ID: 29693745
[TBL] [Abstract][Full Text] [Related]
22. Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.
Maruyama W; Shirakawa K; Matsui H; Matsumoto T; Yamazaki H; Sarca AD; Kazuma Y; Kobayashi M; Shindo K; Takaori-Kondo A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1466-71. PubMed ID: 27577680
[TBL] [Abstract][Full Text] [Related]
23. Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.
Byeon IJ; Byeon CH; Wu T; Mitra M; Singer D; Levin JG; Gronenborn AM
Biochemistry; 2016 May; 55(21):2944-59. PubMed ID: 27163633
[TBL] [Abstract][Full Text] [Related]
24. APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells.
Shinohara M; Io K; Shindo K; Matsui M; Sakamoto T; Tada K; Kobayashi M; Kadowaki N; Takaori-Kondo A
Sci Rep; 2012; 2():806. PubMed ID: 23150777
[TBL] [Abstract][Full Text] [Related]
25. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
26. Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme.
Caval V; Bouzidi MS; Suspène R; Laude H; Dumargne MC; Bashamboo A; Krey T; Vartanian JP; Wain-Hobson S
Nucleic Acids Res; 2015 Oct; 43(19):9340-9. PubMed ID: 26384561
[TBL] [Abstract][Full Text] [Related]
27. Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.
Hou S; Silvas TV; Leidner F; Nalivaika EA; Matsuo H; Kurt Yilmaz N; Schiffer CA
J Chem Theory Comput; 2019 Jan; 15(1):637-647. PubMed ID: 30457868
[TBL] [Abstract][Full Text] [Related]
28. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.
Verhalen B; Starrett GJ; Harris RS; Jiang M
J Virol; 2016 Jul; 90(14):6379-6386. PubMed ID: 27147740
[TBL] [Abstract][Full Text] [Related]
29. APOBEC3B is preferentially expressed at the G2/M phase of cell cycle.
Hirabayashi S; Shirakawa K; Horisawa Y; Matsumoto T; Matsui H; Yamazaki H; Sarca AD; Kazuma Y; Nomura R; Konishi Y; Takeuchi S; Stanford E; Kawaji H; Murakawa Y; Takaori-Kondo A
Biochem Biophys Res Commun; 2021 Mar; 546():178-184. PubMed ID: 33592502
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase-independent activity.
Ma W; Ho DW; Sze KM; Tsui YM; Chan LK; Lee JM; Ng IO
Mol Carcinog; 2019 May; 58(5):643-653. PubMed ID: 30575099
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates.
Liu M; Mallinger A; Tortorici M; Newbatt Y; Richards M; Mirza A; van Montfort RLM; Burke R; Blagg J; Kaserer T
ACS Chem Biol; 2018 Sep; 13(9):2427-2432. PubMed ID: 30130388
[TBL] [Abstract][Full Text] [Related]
32. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.
Shi K; Demir Ö; Carpenter MA; Wagner J; Kurahashi K; Harris RS; Amaro RE; Aihara H
Sci Rep; 2017 Dec; 7(1):17415. PubMed ID: 29234087
[TBL] [Abstract][Full Text] [Related]
33. APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancers.
Tsuboi M; Yamane A; Horiguchi J; Yokobori T; Kawabata-Iwakawa R; Yoshiyama S; Rokudai S; Odawara H; Tokiniwa H; Oyama T; Takeyoshi I; Nishiyama M
Breast Cancer; 2016 Sep; 23(5):780-8. PubMed ID: 26476745
[TBL] [Abstract][Full Text] [Related]
34. Expansions, diversification, and interindividual copy number variations of AID/APOBEC family cytidine deaminase genes in lampreys.
Holland SJ; Berghuis LM; King JJ; Iyer LM; Sikora K; Fifield H; Peter S; Quinlan EM; Sugahara F; Shingate P; Trancoso I; Iwanami N; Temereva E; Strohmeier C; Kuratani S; Venkatesh B; Evanno G; Aravind L; Schorpp M; Larijani M; Boehm T
Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3211-E3220. PubMed ID: 29555777
[TBL] [Abstract][Full Text] [Related]
35. Structural Characterization of a Minimal Antibody against Human APOBEC3B.
Tang H; Demir Ö; Kurniawan F; Brown WL; Shi K; Moeller NH; Carpenter MA; Belica C; Orellana K; Du G; LeBeau AM; Amaro RE; Harris RS; Aihara H
Viruses; 2021 Apr; 13(4):. PubMed ID: 33921405
[TBL] [Abstract][Full Text] [Related]
36. Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA.
Yang Y; Sowden MP; Yang Y; Smith HC
Exp Cell Res; 2001 Jul; 267(2):153-64. PubMed ID: 11426934
[TBL] [Abstract][Full Text] [Related]
37. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
38. Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells.
Yamazaki H; Shirakawa K; Matsumoto T; Hirabayashi S; Murakawa Y; Kobayashi M; Sarca AD; Kazuma Y; Matsui H; Maruyama W; Fukuda H; Shirakawa R; Shindo K; Ri M; Iida S; Takaori-Kondo A
Sci Rep; 2019 May; 9(1):7122. PubMed ID: 31073151
[TBL] [Abstract][Full Text] [Related]
39. Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.
Kohli RM; Maul RW; Guminski AF; McClure RL; Gajula KS; Saribasak H; McMahon MA; Siliciano RF; Gearhart PJ; Stivers JT
J Biol Chem; 2010 Dec; 285(52):40956-64. PubMed ID: 20929867
[TBL] [Abstract][Full Text] [Related]
40. The mechanisms regulating the subcellular localization of AID.
Patenaude AM; Di Noia JM
Nucleus; 2010; 1(4):325-31. PubMed ID: 21327080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
